{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T03:47:30Z","timestamp":1795232850990,"version":"4.10.3"},"reference-count":39,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"unspecified","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012424","name":"UC San Diego School of Medicine","doi-asserted-by":"crossref","award":["Summer Research Training Grant"],"award-info":[{"award-number":["Summer Research Training Grant"]}],"id":[{"id":"10.13039\/100012424","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Biobank: 1 U24 OD023121"],"award-info":[{"award-number":["Biobank: 1 U24 OD023121"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Communications and Engagement: 3 OT2 OD023205; 3 O"],"award-info":[{"award-number":["Communications and Engagement: 3 OT2 OD023205; 3 O"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Community Partners: 1 OT2 OD025277; 3 OT2 OD025315"],"award-info":[{"award-number":["Community Partners: 1 OT2 OD025277; 3 OT2 OD025315"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP5OD029610"],"award-info":[{"award-number":["DP5OD029610"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Data and Research Center: 5 U2C OD023196"],"award-info":[{"award-number":["Data and Research Center: 5 U2C OD023196"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Federally Qualified Health Centers: HHSN 26320160"],"award-info":[{"award-number":["Federally Qualified Health Centers: HHSN 26320160"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Office of the Director: Regional Medical Centers:"],"award-info":[{"award-number":["Office of the Director: Regional Medical Centers:"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30EY022589"],"award-info":[{"award-number":["P30EY022589"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Participant Technology Systems Center: 1 U24 OD02"],"award-info":[{"award-number":["Participant Technology Systems Center: 1 U24 OD02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["The Participant Center: U24 OD023176"],"award-info":[{"award-number":["The Participant Center: U24 OD023176"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2025,8,21]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Few studies have assessed the impact of metformin use on glaucoma risk. The purpose of this study was to examine the association between metformin use and the incidence of primary open-angle glaucoma (POAG) in a diverse and large nationwide cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We included a retrospective cohort study of 18\u2009440 participants in the National Institutes of Health\n                      <jats:italic>All of Us<\/jats:italic>\n                      Research Program aged 40 years or older, with a diagnosis of diabetes mellitus and without a diagnosis of POAG prior to diabetes diagnosis or metformin use. Bivariate logistic regression, multivariable logistic regression and survival analysis were used to analyse the association between ever use of metformin and incidence of POAG.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Within the cohort, 240 participants acquired a diagnosis of POAG during all available follow-up time, while 18\u2009200 did not. In regression-based bivariate analysis, metformin use was significantly associated with a lower odds of developing POAG (OR 0.35, 95% CI 0.26 to 0.47, p&lt;0.001). In multivariable regression analysis, metformin remained protective against POAG (OR 0.33, 95%\u2009CI 0.21 to 0.50, p&lt;0.001), while the use of other diabetic medications was associated with an increased odds of developing POAG (OR 2.39, 95%\u2009CI 1.48 to 3.90, p&lt;0.001). In survival analysis, the probability of developing POAG was significantly lower for the participants using metformin than for the participants not using metformin (log-rank p&lt;0.001, Cox proportional HR 0.38, 95%\u2009CI 0.29 to 0.51).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study provides additional large-scale observational health data supporting the protective role of metformin in the development of POAG. However, limitations include the study\u2019s observational design and lack of data on metformin dosage and duration, glaucoma severity and ocular exam findings. Despite these limitations, our findings contribute to the growing body of evidence suggesting a potential protective effect of metformin against POAG.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjophth-2024-002027","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T11:05:15Z","timestamp":1757675115000},"page":"e002027","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Association of metformin use with primary open-angle glaucoma using data from the National Institutes of Health\n                    <i>All of Us<\/i>\n                    Program"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5371-3483","authenticated-orcid":false,"given":"Sophia","family":"Sidhu","sequence":"first","affiliation":[{"name":"Division of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharanidharan","family":"Radha Saseendrakumar","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California, USA"},{"name":"Division of Biomedical Informatics, Department of Medicine, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Varkhedi","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California, USA"},{"name":"Division of Biomedical Informatics, Department of Medicine, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9435-746X","authenticated-orcid":false,"given":"Jo-Hsuan","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Parikh","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California, USA"},{"name":"Division of Biomedical Informatics, Department of Medicine, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Nudleman","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiun L","family":"Do","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasan","family":"Moghimi","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N","family":"Weinreb","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5271-7690","authenticated-orcid":false,"given":"Sally L","family":"Baxter","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California, USA"},{"name":"Division of Biomedical Informatics, Department of Medicine, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"key":"2026010721210921000_10.1.e002027.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804630"},{"key":"2026010721210921000_10.1.e002027.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.3192"},{"key":"2026010721210921000_10.1.e002027.3","unstructured":"Mahabadi N , Foris LA , Tripathy K . Open angle glaucoma. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2022."},{"key":"2026010721210921000_10.1.e002027.4","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92971-w","article-title":"Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review","volume":"11","author":"Zhang","year":"2021","journal-title":"Sci Rep"},{"key":"2026010721210921000_10.1.e002027.5","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2013.256"},{"key":"2026010721210921000_10.1.e002027.6","doi-asserted-by":"crossref","DOI":"10.3390\/cells10082131","article-title":"Metformin and Glaucoma-Review of Anti-Fibrotic Processes and Bioenergetics","volume":"10","author":"Hurley","year":"2021","journal-title":"Cells"},{"key":"2026010721210921000_10.1.e002027.7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5644\/ama2006-124.196","article-title":"Metformin use associated with protective effects for ocular complications in patients with type 2 diabetes \u2013 observational study","volume":"46","author":"Male\u0161ki\u0107","year":"2017","journal-title":"ama"},{"key":"2026010721210921000_10.1.e002027.8","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jamaophthalmol.2015.1440","article-title":"Association of Geroprotective Effects of Metformin and Risk of Open-Angle Glaucoma in Persons With Diabetes Mellitus","volume":"133","author":"Lin","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"2026010721210921000_10.1.e002027.9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2018.02.002","article-title":"Progression of Primary Open-Angle Glaucoma in Diabetic and Nondiabetic Patients","volume":"189","author":"Hou","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"2026010721210921000_10.1.e002027.10","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1490"},{"key":"2026010721210921000_10.1.e002027.11","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.4103\/ijo.IJO_1486_21","article-title":"Association of metformin use among diabetics and the incidence of primary open-angle glaucoma - The Chennai Eye Disease Incidence Study","volume":"69","author":"George","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"2026010721210921000_10.1.e002027.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr1809937"},{"key":"2026010721210921000_10.1.e002027.13","unstructured":"All of us research program operational protocol. 2018."},{"key":"2026010721210921000_10.1.e002027.14","unstructured":"What is snomed? us res. Available: https:\/\/www.researchallofus.org\/faq\/what-is-snomed\/ [Accessed 13 Jul 2022]."},{"key":"2026010721210921000_10.1.e002027.15","unstructured":"All of Us Researcher Workbench: Metformin and Glaucoma, Available: https:\/\/workbench.researchallofus.org\/workspaces\/aou-rw-244e4adf\/metforminandglaucoma\/notebooks [Accessed 13 Jul 2022]."},{"key":"2026010721210921000_10.1.e002027.16","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(76)90073-4"},{"key":"2026010721210921000_10.1.e002027.17","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-024-02145-x","article-title":"Double diabetes-when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition","volume":"23","author":"Bielka","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"2026010721210921000_10.1.e002027.18","doi-asserted-by":"crossref","first-page":"718942","DOI":"10.3389\/fendo.2021.718942","article-title":"A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan","volume":"12","author":"Mohammed","year":"2021","journal-title":"Front Endocrinol"},{"key":"2026010721210921000_10.1.e002027.19","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2801450","article-title":"Association of Metformin Treatment with Reduced Severity of Diabetic Retinopathy in Type 2 Diabetic Patients","volume":"2018","author":"Li","year":"2018","journal-title":"J Diabetes Res"},{"key":"2026010721210921000_10.1.e002027.20","unstructured":"Zhongshan Ophthalmic Center, Sun Yat-sen University . Effect of metformin on visual function in patients with primary open angle glaucoma: a randomized control study. clinicaltrials.gov; 2022."},{"key":"2026010721210921000_10.1.e002027.21","unstructured":"Christopher P . Metformin as a neuroprotective therapy for glaucoma - a randomized controlled trial. clinicaltrials.gov; 2022."},{"key":"2026010721210921000_10.1.e002027.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(03)00028-6"},{"key":"2026010721210921000_10.1.e002027.23","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-307223"},{"key":"2026010721210921000_10.1.e002027.24","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3109\/08820538.2016.1154165","article-title":"Glaucoma Disparities in the Hispanic Population","volume":"31","author":"Nathan","year":"2016","journal-title":"Semin Ophthalmol"},{"key":"2026010721210921000_10.1.e002027.25","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e3283360b7e"},{"key":"2026010721210921000_10.1.e002027.26","doi-asserted-by":"crossref","first-page":"100013","DOI":"10.1016\/j.ajoint.2024.100013","article-title":"Glaucoma in women: What do we know so far - A systematic review","volume":"1","author":"Rizk","year":"2024","journal-title":"AJO International"},{"key":"2026010721210921000_10.1.e002027.27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151833","article-title":"Increased Intraocular Pressure and Hyperglycemic Level in Diabetic Patients","volume":"11","author":"Hymowitz","year":"2016","journal-title":"PLoS One"},{"key":"2026010721210921000_10.1.e002027.28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/IJG.0000000000000096","article-title":"Comparison of Optic Nerve Head Topographic Parameters in Patients With Primary Open-Angle Glaucoma With and Without Diabetes Mellitus","volume":"25","author":"Akkaya","year":"2016","journal-title":"J Glaucoma"},{"key":"2026010721210921000_10.1.e002027.29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ogla.2020.09.013","article-title":"Effect of Diabetes Control on Rates of Structural and Functional Loss in Patients with Glaucoma","volume":"4","author":"Johnson","year":"2021","journal-title":"Ophthalmol Glaucoma"},{"key":"2026010721210921000_10.1.e002027.30","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.63.5.37","article-title":"Type 2 Diabetes, Fasting Glucose, Hemoglobin A1c Levels and Risk of Primary Open-Angle Glaucoma: A Mendelian Randomization Study","volume":"63","author":"Hu","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2026010721210921000_10.1.e002027.31","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.400"},{"key":"2026010721210921000_10.1.e002027.32","doi-asserted-by":"crossref","unstructured":"Li X , Leng Y , Jiang Q , et al . Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats via Activating AMPK\/Nrf2 Signaling Pathway. Front Pharmacol 2020;11. doi:10.3389\/fphar.2020.01038","DOI":"10.3389\/fphar.2020.01038"},{"key":"2026010721210921000_10.1.e002027.33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/IJG.0000000000002387","article-title":"Metformin in Glaucoma Treatment","volume":"33","author":"Daka","year":"2024","journal-title":"J Glaucoma"},{"key":"2026010721210921000_10.1.e002027.34","unstructured":"Holman R . Metformin as first choice in oral diabetes treatment: the UKPDS experience. Journ Annu Diabetol Hotel Dieu 2007;13\u201320."},{"key":"2026010721210921000_10.1.e002027.35","doi-asserted-by":"publisher","DOI":"10.2337\/cd16-0067"},{"key":"2026010721210921000_10.1.e002027.36","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1080\/03007995.2022.2085962","article-title":"Are we there yet? Increasing use of cardioprotective antihyperglycemic agents in patients with T2D and CVD or CV risk in the United States","volume":"38","author":"Mody","year":"2022","journal-title":"Curr Med Res Opin"},{"key":"2026010721210921000_10.1.e002027.37","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-S009"},{"key":"2026010721210921000_10.1.e002027.38","first-page":"S60","article-title":"5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes\u20142022","volume":"45","year":"2021","journal-title":"Diabetes Care"},{"key":"2026010721210921000_10.1.e002027.39","unstructured":"Wexler DJ . Initial management of hyperglycemia in adults with type 2 diabetes mellitus. UpToDate, 2022."}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2024-002027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:22:09Z","timestamp":1767849729000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2024-002027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,9,12]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/bmjophth-2024-002027"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2024-002027","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}